Navigation Links
Two-Year Results from the Medtronic ENDEAVOR III Trial Confirm,Stent's Positive Clinical Profile

olled in its multiple clinical trials, and the growing volume of positive data and number of patients with long-term follow-up continues to reinforce the stent's favorable safety and efficacy profile. The Endeavor stent is not yet approved for use in the United States.

"With two years of follow-up in nearly 1,300 patients and the volume of positive clinical data we've seen to date, we can continue to have confidence in Endeavor's clinical performance," said Martin Leon, M.D., principal investigator of the ENDEAVOR III clinical trial and Professor of Medicine at Columbia University School of Medicine. "As the Endeavor clinical program has matured, it has provided evidence that consistent and predictable patient outcomes are being sustained through time."

Scott Ward, senior vice president at Medtronic and president of the Vascular business, added: "The Endeavor clinical program continues to generate strong cumulative evidence regarding Endeavor's overall performance. Patients have been 99.7% free from overall stent thrombosis and we've seen no late stent thrombosis in our pooled clinical trials. In addition, Endeavor has demonstrated a sustained reduction in repeat procedures of 61% compared to the Medtronic Driver(R) bare metal stent and Endeavor's death/MI rates have been trending lower than bare metal stents."

Medtronic will present additional long-term data on Endeavor in the coming months. At the EuroPCR meeting in May, Medtronic will provide updated four-year and three-year results from the ENDEAVOR I and ENDEAVOR II trials respectively, as well as new data on the next-generation Endeavor Resolute drug-eluting stent. Results from the ongoing ENDEAVOR IV trial, another large randomized trial (1,548 patients) evaluating Endeavor against the Taxus stent made by Boston Scientific, are expected to be presented in the fall.

The Endeavor stent is made of a cobalt alloy and has a unique modular architecture designed to enhance deliverability
'"/>




Page: 1 2 3

Related medicine technology :

1. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
2. Two-Year Patient Registry Results Support Safety and Efficacy of Cypher Sirolimus-Eluting Coronary Stent in Real World Uses
3. Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
4. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
5. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
6. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
7. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
8. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
9. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
Post Your Comments:
(Date:6/17/2013)... June 17, 2013  As the Share Repurchase Resolution has ... Offer for Elan Corporation, plc (NYSE: ELN ) ... outcome of the Proceedings referred to below and any consequent ... to be effective to the extent that it would have ... of the Share Repurchase Resolution being passed. There can be ...
(Date:6/17/2013)... PARSIPPANY, N.J. , June 17, 2013 Actavis, ... United States Supreme Court has reversed the decision of the ... affirmed the District Court,s ruling granting Actavis, motion to dismiss ... .  The Supreme Court,s reversal was the result of a ... the FTC,s proposed "quick look" approach and adopted the traditional ...
(Date:6/17/2013)... , June 17, 2013 The Biozoom ... portable, hand held device for the non-invasive transdermal ... human body. It replaces expensive, time consuming and ... a button, the Biozoom scanner reflects a beam ... Zeiss—and measures the reflection. Using the scanner, researchers ...
Breaking Medicine Technology:Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 2Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 3Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 4Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 5Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 6Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 7Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 8Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 9Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 10U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis 2U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis 3University Researchers Use Biozoom Scanner To Investigate Relationship Between Stress And Work 2University Researchers Use Biozoom Scanner To Investigate Relationship Between Stress And Work 3University Researchers Use Biozoom Scanner To Investigate Relationship Between Stress And Work 4
... Sheffield Bio-Science, a leading global pharmaceutical supplier of superior ... markets, has been awarded the distinguished 2010 Lilly Global Supplier Award. ... The ... and services for Eli Lilly and Company over the years and ...
... ATLANTA , July 12 Holon, the new ... Medication Management solution. , ... Leveraging the Holon Process Adaptive Interoperability Framework, ... your current medication management solution by automating the collection and ...
Cached Medicine Technology:Sheffield Bio-Science Wins 2010 Lilly Global Supplier Award 2Holon: The Process Adaptive Interoperability Framework 2
(Date:6/17/2013)... Essential tremor (ET) is the most common ... people in the United States, and millions more worldwide. ... causes ET, there are no medications specifically designed to ... Tremor© is the International Essential Tremor Foundation’s annual research ... cure for this life-altering neurological condition. , “Although millions ...
(Date:6/17/2013)... of people who registered themselves as organ donors 21-fold ... social media might be an effective tool to address ... The gains were made in May 2012 when the ... share their organ donor status with friends and provided ... department of motor vehicle websites. The findings are being ...
(Date:6/17/2013)... June 17, 2013 Bust’DD (pronounced ‘busted’), a ... and well-fitting to women with large busts, will soon launch ... two women who understand the problem of ill-fitting bras and ... women. Their goal is to raise at least $25,000 to ... offering their bras on a wide scale. , In order ...
(Date:6/17/2013)... 2013 The producers of Impact with ... of reports highlighting how sustainable farming techniques are helping ... and their demand on food supplies. , Impact ... series airing in markets around the country on public ... Sheen, who is marking the start of his second ...
(Date:6/17/2013)... As da Vinci robot lawsuit claims ... Liebhard LLP notes that a recent report aired on ... disturbing robotic surgery complications alleged to have been caused by ... June 14th broadcast revealed that the U.S. Food & Drug ... Vinci patients who suffered burns, cuts and infections since 2007. ...
Breaking Medicine News(10 mins):Health News:International Essential Tremor Foundation Kicks Off Annual Essential Tremor Research Fundraiser, Tulips for Tremor 2Health News:The Facebook effect: Social media dramatically boosts organ donor registration 2Health News:The Facebook effect: Social media dramatically boosts organ donor registration 3Health News:Arizona Startup Bust’DD Looking to Start a BRAvolution 2Health News:Arizona Startup Bust’DD Looking to Start a BRAvolution 3Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on NBC Report Detailing Robotic Surgery Complications 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on NBC Report Detailing Robotic Surgery Complications 3
... the Children of Love Canal Are Not Counted In the ... Speak &,Ask What Have We Learned?, FALLS CHURCH, Va., ... for Health, Environment & Justice:, WHAT:, Press Conference ... Love Canal once stood., Rain or Shine, WHEN:, ...
... YORK, July 26, 2008 The following news tips are ... 2008 International Conference to be held in Chicago from July ... specific date and time. , Brain Atrophy and Biomarkers ... Susan de Santi, Ph.D., Associate Professor, Department of Psychiatry, NYU ...
... FE SPRINGS, Calif., July 29 IQAir announced ... (USOC) with ultra-high,efficiency air cleaning for USA athletes ... the optimum performance environment., (Photo: http://www.newscom.com/cgi-bin/prnh/20080729/LATU099 ... able to support the performance efforts of the,USOC ...
... SAN JOSE, Calif., July 29 VNUS(R) Medical,Technologies, Inc. (Nasdaq: ... for the full year 2008. Full-year 2008 net income is ... income of $0.77,to $0.85 per share which is changed from ... or income of $0.68 to $0.74 per,share., ABOUT VNUS ...
... AGAWAM, Mass., July 29 Microtest Laboratories has,launched ... compounding pharmacies,in the U.S. that have yet failed ... 797) regulations. Microtest also announced,its offer of a ... USP 797 compliance level and corresponding,preparation., Pharmacies ...
... Health and Charitable Care and Coverage, OAKLAND, ... it has approved more than 415 community benefit ... second quarter of 2008.,The quarter,s contributions continue to ... a measurable impact on the health of,its communities., ...
Cached Medicine News:Health News:30 Years After State of Emergency Declared at Love Canal, NY Closing the 99th Street School Triggering the Federal Superfund Program; Schools & Communities Across the Nation Still at Risk of Toxic Contamination 2Health News:New Alzheimer's predictors advance earlier detection 2Health News:New Alzheimer's predictors advance earlier detection 3Health News:New Alzheimer's predictors advance earlier detection 4Health News:New Alzheimer's predictors advance earlier detection 5Health News:New Alzheimer's predictors advance earlier detection 6Health News:New Alzheimer's predictors advance earlier detection 7Health News:New Alzheimer's predictors advance earlier detection 8Health News:IQAir to Provide U.S. Athletes With Ultra-High Efficiency Air Cleaning at the Beijing 2008 Olympic Games 2Health News:VNUS Revises Upward Full-Year 2008 Net Income Guidance 2Health News:Microtest Offers New Services, Free Facility Audit, for Compounding Pharmacies Seeking USP 797 Compliance 2Health News:Microtest Offers New Services, Free Facility Audit, for Compounding Pharmacies Seeking USP 797 Compliance 3Health News:Kaiser Permanente Approves $22 Million in Community Benefit Grants in Second Quarter of 2008 2Health News:Kaiser Permanente Approves $22 Million in Community Benefit Grants in Second Quarter of 2008 3
... The QuickVue Influenza A+B test allows ... influenza type A and type B ... wash and/or nasal aspirate specimens. The ... in the rapid differential diagnosis of ...
... Antibody Detection Assay is a single use, ... (first step) detection of IgG and IgM ... or whole blood. Rapid turnaround time, ease ... Wampole PreVue B. burgdorferi antibody detection test ...
... Conforming to U.S. and international ... Nephew's TC-100 Screw and Plating System* ... and ease of use for open ... However, the TC-100 system works well ...
Comprehensive range of integrated implants and instruments including - Basic, Small, Mini, Pelvic and Foot Sets....
Medicine Products: